⌘K

Login Start Free

Home/Filings/4/0001562180-24-000396

4//SEC Filing

GUYER DAVID R 4

Accession 0001562180-24-000396

CIK 0001314102other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 8:56 PM ET

Size

5.6 KB

Accession

0001562180-24-000396

Insider Transaction Report

Form 4

Period: 2024-01-05

EyePoint Pharmaceuticals, Inc.EYPT

Director

Transactions

Award
Stock Option (Right to Buy)
2024-01-05+25,014→ 25,014 total
Exercise: $20.40From: 2025-01-05Exp: 2034-01-04→ Common Stock (25,014 underlying)

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1

filerCIK 0001277476

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 8:56 PM ET
Size: 5.6 KB

View on SEC.gov